GSCN Workshop "Disease Modeling & Drug Development" on 16 & 17 Nov. in Bonn
This two-day workshop will bring together experts from stem cell-based disease modeling and drug development and address the latest developments in this rapidly expanding field. The event will feature expert talks from academia and pharma, moderated discussion rounds and short project vignettes by the workshop participants.
Topics to be addressed range from biological and infrastructural prerequisites for stem cell-based drug discovery to strategic issues such as proper placement of stem cell tools in the pharmaceutical value chain. We expect a focused and highly interactive event on the beautiful Bonn Medical Campus and look forward to your participation!
More information here

The ISSCR has published an updated guide about stemcell treatments with ressourceful information for patients, recommendations for questions and considerations before deciding on a stemcell therapie and the risk of unproven stemcell therapies.  The educational resource empowers patients and the public with trusted, essential stem cell knowledge to make informed health decisions. The Guide was written by international scientists.
Find more information in English and German here.

EN (➙ DE)
The German Stem Cell Network (GSCN) has identified changing societal attitudes in Germany towards human embryonic stem cell research in an online survey. When the Stem Cell Act was passed nearly 20 years ago, society stood behind the ban on generating human embryonic stem cells in Germany or using them for research (with few exceptions).
Today, things look different: The majority of respondents, but especially all survey participants with a proven interest in life sciences, affirm research with human embryonic stem cells and also support the generation and import of current stem cell lines. They are convinced that the German Embryo Protection Act of 1990 and the Stem Cell Act of 2007 should be amended to a more research-positive wording.
More information and the data of the survey ➙ here.

DE:
Das German Stem Cell Network (GSCN) hat bei einer Online-Umfrage veränderte gesellschaftliche Einstellungen in Deutschland zur Forschung mit humanen embryonalen Stammzellen festgestellt. Als vor knapp 20 Jahren das Stammzellgesetz verabschiedet wurde, stand die Gesellschaft hinter dem Verbot, in Deutschland humane embryonale Stammzellen herzustellen oder für die Forschung (mit wenigen Ausnahmen) zu verwenden.
Heute sieht das anders aus: Die Mehrheit der Befragten, ganz besonders aber alle Umfrageteilnehmer*innen mit ausgewiesenem Interesse an Lebenswissenschaften, bejahen die Forschung mit humanen embryonalen Stammzellen und befürworten auch die Herstellung und Import von aktuellen Stammzelllinien. Ihrer Überzeugung nach sollten das deutsche Embryonenschutzgesetz von 199o und das Stammzellgesetz von 2007 geändert werden zu einer forschungspositiveren Formulierung.
Mehr Informationen und die Daten der Umfrage ➙ hier.

The "GSCN 2023 Young Investigator Award" goes to Meike Hohwieler from the Institute of Molecular Oncology and Stem Cell Biology at Ulm University Hospital.

The "GSCN 2023 Hilde Mangold Award" goes to Anne Grapin-Botton from the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG) in Dresden.

The "GSCN 2023 Publication of the Year Award" goes to Ruzhica Bogeska, ... Michael D. Milsom from Division of Experimental Hematology, German Cancer Research Center (DKFZ) & HI-STEM, receive the GSCN 2023 Publication of the Year Award for the publication “Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging” in the journal Cell Stem Cell, Aug. 2022.

Find the GSCN press release   
Finden Sie die Pressemitteilung auf Deutsch  
Find more information here

The 11^th GSCN Conference featured excellent keynote speaker:

    
M. Goodell     Jan Lohmann     H. Nakauchi        Maike Sander     Fiona Watt
(Houston)      (Heidelberg)       (Stanford)            (Berlin)                (Heidelberg)

It was a an excellent conference with a dense program with national and international highlights, broad poster sessions, many presentations from all fields of stem cell research, two social get-togethers and an exciting  industry exhibition in Ulm.
All information ➙ here

The International Society for Stem Cell Research (ISSCR) has published an updated 
Guide to Stem Cell Treatment
It is central to the society’s mission to share scientifically accurate information to inform patients and families about the current state of stem cell research and potential treatments. The ISSCR aims to further patient safety and public health through our efforts to promote legitimate stem cell research and credible stem cell treatments.

Stem Cell Research and Diseases IV

Content: 
- Regenerative therapies for skin and cornea
- Degenerative muscle diseases
- Hair loss and regeneration
- Rare diseases
- Improving the transparency, reproducibility and ethical conduct of research
- and more articles ...

Starting in 2021, the German Stem Cell Network (GSCN) and the Berlin Institute of Health (BIH) have entered into a close cooperation with the foundation of the "Dialog Platform Stem Cell Research".
Find the press release with more information here.

Through this White Paper, the GSCN and the Interdisciplinary  Research Group (IAG) Gene Technology Report of the Berlin-Brandenburg Academy of Sciences and Humanities (BBAW) hope to raise public awareness of this research field and stimulate an interdisciplinary public debate on organoids.
Read more

The GSCN has developed an exhibition for institutes, universities and teachers - 10 posters on topics of current stem cell research like diabetes, organoids, skin, ethics and many more. Each poster is accompanied by a website with videos, factsheets and an interactive quiz to deepen the information.
Link to the website in German: Stammzellen - Zellen fürs Leben
Link to the website in English: Stem Cells for Life
Contact: gscn.office@mdc-berlin.de